scispace - formally typeset
M

Matthias Schlesner

Researcher at German Cancer Research Center

Publications -  183
Citations -  27040

Matthias Schlesner is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 42, co-authored 152 publications receiving 17867 citations. Previous affiliations of Matthias Schlesner include University of Marburg & Max Planck Society.

Papers
More filters
Journal ArticleDOI

Signatures of mutational processes in human cancer

Ludmil B. Alexandrov, +84 more
- 22 Aug 2013 - 
TL;DR: It is shown that hypermutation localized to small genomic regions, ‘kataegis’, is found in many cancer types, and this results reveal the diversity of mutational processes underlying the development of cancer.
Journal ArticleDOI

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

TL;DR: The power of ComplexHeatmap is demonstrated to easily reveal patterns and correlations among multiple sources of information with four real-world datasets.
Journal ArticleDOI

circlize Implements and enhances circular visualization in R.

TL;DR: The circlize package is presented, which provides an implementation of circular layout generation in R as well as an enhancement of available software and the flexibility of this package is based on the usage of low-level graphics functions such that self-defined high- level graphics can be easily implemented by users for specific purposes.
Journal ArticleDOI

Pan-cancer analysis of whole genomes

Peter J. Campbell, +1332 more
- 06 Feb 2020 - 
TL;DR: The flagship paper of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium describes the generation of the integrative analyses of 2,658 whole-cancer genomes and their matching normal tissues across 38 tumour types, the structures for international data sharing and standardized analyses, and the main scientific findings from across the consortium studies.
Journal ArticleDOI

The landscape of genomic alterations across childhood cancers

Susanne Gröbner, +185 more
- 15 Mar 2018 - 
TL;DR: The data suggest that 7–8% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.